Rockwell Medical, Inc.(RMTI)Earnings, Financials & Key RatiosRockwell Medical, Inc. (RMTI) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's persistent net losses and the decline in cash reserves to $9.6 million as of 2026Q1 indicate a high risk of continued shareholder dilution and liquidity constraints.
Rockwell Medical, Inc. (RMTI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Rockwell Medical, Inc. (RMTI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.04vs $0.01-300.0% | $17.3Bvs $18.0B-3.4% |
| Q2 2026 | Mar 26, 2026 | $0.01vs $0.04-125.0% | $18Mvs $19M-1.4% |
| Q4 2025 | Nov 12, 2025 | $0.05vs $0.04-25.0% | $16Mvs $19M-14.3% |
| Q3 2025 | Aug 14, 2025 | $0.05vs $0.05+0.0% | $16Mvs $16M-1.6% |
Recent stock market news and headlines for Rockwell Medical, Inc. (RMTI)
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.
Key metrics vs top competitors for Rockwell Medical, Inc. (RMTI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.19 | $20.49M | -3.46 | -31.76% | -7.67% | -15.28% | — | |
| $64.39 | $1.26B | -6.62 | -43.89% | -284.18% | -87% | — | |
| $2.34 | $1.04B | -16.71 | 60.24% | -37.46% | -18.64% | — | |
| $47.41 | $2.73B | -69.72 | 8.63% | -3.74% | -2.73% | — | |
| $77.01 | $9.13B | 30.08 | 37.55% | 23.13% | 126.27% | — | |
| $10.31 | $1.43B | -1.00 | -2.75% | -43.5% | -50.65% | — |
Rockwell Medical, Inc. (RMTI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Rockwell Medical, Inc. (RMTI) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 8, 2026·SEC
May 7, 2026·SEC
May 7, 2026·SEC
Get notified when RMTI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Rockwell Medical, Inc. (RMTI) stock FAQ — growth, dividends, profitability & financials explained
Rockwell Medical, Inc. (RMTI) reported $67.7M in revenue for fiscal year 2025. This represents a 1951% increase from $3.3M in 1997.
Rockwell Medical, Inc. (RMTI) saw revenue decline by 31.8% over the past year.
Rockwell Medical, Inc. (RMTI) reported a net loss of $5.4M for fiscal year 2025.
Rockwell Medical, Inc. (RMTI) has a return on equity (ROE) of -15.3%. Negative ROE indicates the company is unprofitable.
Rockwell Medical, Inc. (RMTI) generated $1.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
